PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
In a clinical report of 33 subjects, the plant extract significantly attenuated stress and anxiety and improved depression without altering memory or concentration [PMID:17593676]
In rats, aqueous root extract decreased sleep latency and increased the duration of non-rapid eye movement (NREM) sleep and total sleep [PMID:22766307]
Rhizome extract showed antioxidant and anti-inflammatory effects against MPTP-induced neurodegeneration in mice [PMID:26522450]
Dichloromethane extract of the patchouli alcohol chemotype significantly reduced immobility in the forced swim test and increased forebrain norepinephrine and dopamine levels in mice [PMID:21354297]
Bornyl 3-phenylpropanoate reduced parasite burden and prevented swelling in L. major-infected mice [PMID:26554591]
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 26522450 (2015) — Neuroprotective effect of Valeriana wallichii rhizome extract against the neurotoxin MPTP in C57BL/6 mice. · Neurotoxicology
- 2.PMID: 29348082 (2018) — Nephrotoxic effects of Valeriana wallichii. · Pakistan journal of pharmaceutical sciences
- 3.PMID: 28623738 (2017) — Iridoids from the roots of Valeriana jatamansi Jones. · Phytochemistry
- 4.PMID: 26009656 (2015) — Essential oil composition of valeriana jatamansi jones from himalayan regions of India. · Indian journal of pharmaceutical sciences
- 5.PMID: 31973064 (2020) — Physiological, Biochemical and Reproductive Studies on Valeriana wallichii, a Critically Endangered Medicinal Plant of the Himalayan Region Grown under In-Situ and Ex-Situ Conditions.